Data Insights

SIR-9900 by Sironax for Neurodegenerative Diseases: Likelihood of Approval

SIR-9900 is under clinical development by Sironax and currently in Phase I for Neurodegenerative Diseases. According to GlobalData, Phase I...

Likelihood of Approval and Phase Transition Success Rate Model - SIR-9900 in Neurodegenerative Diseases

Data Insights

SIR-9900 by Sironax for Inflammation: Likelihood of Approval

SIR-9900 is under clinical development by Sironax and currently in Phase I for Inflammation. According to GlobalData, Phase I drugs...

Likelihood of Approval and Phase Transition Success Rate Model - SIR-9900 in Inflammation

Data Insights

SIR-2501 by Sironax for Neuropathy: Likelihood of Approval

SIR-2501 is under clinical development by Sironax and currently in Phase I for Neuropathy. According to GlobalData, Phase I drugs...

Data Insights

SIR-2501 by Sironax for Neurodegenerative Diseases: Likelihood of Approval

SIR-2501 is under clinical development by Sironax and currently in Phase I for Neurodegenerative Diseases. According to GlobalData, Phase I...

Data Insights

SIR-2446 by Sironax for Alzheimer's Disease: Likelihood of Approval

SIR-2446 is under clinical development by Sironax and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase I...

Likelihood of Approval and Phase Transition Success Rate Model - SIR-2446 in Alzheimer's Disease

Data Insights

SIR-2446 by Sironax for Multiple Sclerosis: Likelihood of Approval

SIR-2446 is under clinical development by Sironax and currently in Phase I for Multiple Sclerosis. According to GlobalData, Phase I...

Likelihood of Approval and Phase Transition Success Rate Model - SIR-2446 in Multiple Sclerosis